(Q38328753)

2 September 2017

Cytokine gene transcription by NF-kappa B family members in patients with inflammatory bowel disease (English)

1 reference

inflammatory bowel diseases

2 September 2017

0 references

0 references

0 references

Neurath MF

1

1 reference

2 September 2017

Fuss I

2

1 reference

2 September 2017

Schürmann G

3

1 reference

2 September 2017

Pettersson S

4

1 reference

2 September 2017

Arnold K

5

1 reference

2 September 2017

Müller-Lobeck H

6

1 reference

2 September 2017

Strober W

7

1 reference

2 September 2017

Herfarth C

8

1 reference

2 September 2017

Büschenfelde KH

9

1 reference

2 September 2017

language of work or name

English

0 references

publication date

1 November 1998

1 reference

Annals of the New York Academy of Sciences

2 September 2017

1 reference

2 September 2017

859

1 reference

2 September 2017

149-159

1 reference

The regulation of immune responses to dietary protein antigens.

2 September 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1998.TB11119.X

Inhibition of Th1 responses prevents inflammatory bowel disease in scid mice reconstituted with CD45RBhi CD4+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1998.TB11119.X

T cells in inflammatory bowel disease: protective and pathogenic roles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1998.TB11119.X

Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1998.TB11119.X

The ubiquitin-proteasome proteolytic pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1998.TB11119.X

TGF beta 1 inhibits NF-kappa B/Rel activity inducing apoptosis of B cells: transcriptional activation of I kappa B alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1998.TB11119.X

Dif, a dorsal-related gene that mediates an immune response in Drosophila.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1998.TB11119.X

Mechanistic aspects of NF-kappa B regulation: the emerging role of phosphorylation and proteolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1998.TB11119.X

NF-kappa B: a pleiotropic mediator of inducible and tissue-specific gene control

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1998.TB11119.X

Activation in vitro of NF-kappa B by phosphorylation of its inhibitor I kappa B

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1998.TB11119.X

Targeted disruption of the p50 subunit of NF-kappa B leads to multifocal defects in immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1998.TB11119.X

Multiorgan inflammation and hematopoietic abnormalities in mice with a targeted disruption of RelB, a member of the NF-kappa B/Rel family

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1998.TB11119.X

Rel-deficient T cells exhibit defects in production of interleukin 3 and granulocyte-macrophage colony-stimulating factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1998.TB11119.X

Inhibition of endothelial cell activation by adenovirus-mediated expression of I kappa B alpha, an inhibitor of the transcription factor NF-kappa B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1998.TB11119.X

10.1111/J.1749-6632.1998.TB11119.X

21 January 2018

Identifiers

DOI

1 reference

2 September 2017

1 reference